ArticleJournal for immunotherapy of cancer2024

Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma.

Yu Jen Alexander Jan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.